Pyridostigmine Other names: Pyridostigmine bromide

Chemical formula: C₉H₁₃N₂O₂+  Molecular mass: 181.212 g/mol  PubChem compound: 4991

Therapeutic indications

Pyridostigmine is indicated for:

Myasthenia gravis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Myasthenia gravis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Myasthenia gravis

Population group: only children (1 year - 12 years old)

Myasthenia gravis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Paralytic ileus, post-operative urinary retention

Population group: only adults (18 years old or older)

at least one of
Paralytic ileus
Postoperative retention of urine

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pyridostigmine is contraindicated in the following cases:

Mechanical gastro-intestinal or urinary obstruction

at least one of

Mechanical ileus
Mechanical urinary obstruction

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: MESTINON Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈